welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
-
Washington University School of MedicineWashington University School of Medicine...
-
Limitless FAP Cliphttps://www.youtube.com/watch?v=aoVWdnB3...
-
Nicholas O. Davidson, MDProfessor, Medicine, Director, Departmen...
-
Ostomy: Diet and Nutrition GuideThis guide provides some basic informati...
-
John M. Carethers, MDCurrent Position: Professor, Internal Me...
-
Judy E. Garber, MD, MPHDr. Garber received her MD and MPH in 19...
-
Appropriate Use of Endoscopy in the Diagnosis and Treatment of Gastrointestinal Diseases: Up-to-date Indications for...The field of endoscopy has revolutionize...